Should I buy Albemarle Corporation (ALB) stock or is it too late?

Albemarle Corporation · Materials · price $136

See the full Albemarle Corporation (ALB) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 64% of its targets hit on this sector (176 calls tested). It aims for $175 (+29 %), call made on August 8, 2026, maturing on August 8, 2027 (20 d ago).

The 5 reliable analysts $175+29 %

The 6 other firms $205+51 %

How to read it: the 5 reliable firms are not filtered by optimism — 5 aim above the price, 0 below, hence their $175 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Albemarle Corporation

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
UBS	69 %	+68.1 %	13	$175 +29%
Jefferies	58 %	+29.5 %	12	$230 +69%
BMO Capital	44 %	+26.6 %	9	$136 +0%
Deutsche Bank	40 %	+0.3 %	20	$185 +36%
Keybanc	29 %	-3.8 %	34	$87 -36%
Oppenheimer	27 %	-10.5 %	15	$207 +52%
B of A Securities	33 %	-12.0 %	9	$225 +66%
Baird	17 %	-23.6 %	6	$210 +55%

In short — Should you invest in Albemarle Corporation? Is it too late, still worth it? Analysts are fairly positive (64% buy, median target $190, i.e. +40%), and the most reliable on ALB targets even higher. But the valuation is stretched (P/E ~503). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

64% of analysts rate it a buy (Buy consensus, 11 ratings) — a sign of market conviction.
Median price target $190, i.e. +40% from the current price ($136).
The most reliable firm on ALB, UBS (69% hit rate, 13 scored calls), targets $175 (call made on August 8, 2026, maturing on August 8, 2027) (+29%) in its most recent call, and $107 (call made on November 13, 2025, maturing on November 13, 2026) (-21%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 11 ratings, 4 are neutral.
High valuation (P/E ~503): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on ALB

Median target $190 (+40%) · 11 ratings · Buy consensus

Strong Buy00%

Buy764%

Hold436%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Albemarle Corporation now?

We won't decide for you. The facts: 64% of analysts rate it a buy, median target $190 (+40%), and UBS (most reliable on ALB, 69%) targets $175. Weigh that against valuation (P/E ~503). This is not personalized advice.

Is it too late to invest in Albemarle Corporation?

Not according to analysts: the median target ($190) is still +40% above the current price ($136) (most reliable on ALB: UBS, 69%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Albemarle Corporation still worth investing in?

It depends on the gap between the price ($136) and its estimated value: analysts target $190 on median (+40%), with 64% buys (most reliable on ALB: UBS, 69%). Cross-check with their real reliability on ALB and the cautions above. Information, not advice.

What's the main risk in buying ALB?

The consensus is not unanimous: of 11 ratings, 4 are neutral.

→ Go deeper: the full Albemarle Corporation profile (consensus, analyst reliability, price target, performance).